{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T04:10:15Z","timestamp":1745035815488,"version":"3.40.4"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,4,15]]},"DOI":"10.2169\/internalmedicine.4234-24","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T22:10:30Z","timestamp":1725401430000},"page":"1275-1279","source":"Crossref","is-referenced-by-count":2,"title":["Disseminated Nontuberculous Mycobacterium Infection During Treatment of Multiple Myeloma: A Case Report and Review of the Literature"],"prefix":"10.2169","volume":"64","author":[{"given":"Takatoshi","family":"Kitazawa","sequence":"first","affiliation":[{"name":"Department of Medicine, Teikyo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Teikyo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Medicine, Teikyo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyotaro","family":"Kawase","sequence":"additional","affiliation":[{"name":"Department of Medicine, Teikyo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Teikyo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nucci M, Anaissie E. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis 49: 1211-1225, 2009.","DOI":"10.1086\/605664"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Teh BW, Harrison SJ, Worth LJ, Spelman T, Thursky KA, Slavin MA. Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy. Br J Haematol 171: 100-108, 2015.","DOI":"10.1111\/bjh.13532"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chen CY, Sheng WH, Lai CC, et al. Mycobacterial infections in adult patients with hematological malignancy. Eur J Clin Microbiol Infect Dis 31: 1059-1066, 2012.","DOI":"10.1007\/s10096-011-1407-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Inoue Y, Ishii H, Hirakata Y, Maesaki S, Tomono K, Kohno S. [Pulmonary infection in the emphysematous bulla due to <i>Mycobacterium szulgai<\/i> diagnosed by percutaneus needle aspiration]. Kansenshogaku Zasshi (J Jpn Assoc Infect Dis) 72: 1236-1241, 1998 (in Japanese).","DOI":"10.11150\/kansenshogakuzasshi1970.72.1236"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tejan-Sie SA, Avery RK, Mossad SB. <i>Mycobacterium fortuitum<\/i> osteomyelitis in a peripheral blood stem cell transplant recipient. Scand J Infect Dis 32: 94-96, 2000.","DOI":"10.1080\/00365540050164317"},{"key":"6","unstructured":"6. Nishizawa Y, Fujimura M, Tagami A, et al. [Two cases of pulmonary infection by <i>Mycobacterium abscessus<\/i> in which drug susceptibility testing results conflicted with clinical courses]. Nihon Kokyuki Gakkai Zasshi (Ann Jpn Respir Soc) 43: 241-246, 2005 (in Japanese)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Campos-Herrero MI, Garc\u00eda D, Figuerola A, Su\u00e1rez P, Campo C, Garc\u00eda MJ. Bacteremia caused by the novel species <i>Mycobacterium canariasense<\/i>. Eur J Clin Microbiol Infect Dis 25: 58-60, 2006.","DOI":"10.1007\/s10096-005-0079-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Guerra Laso J, Mor\u00e1n Blanco A, Lorenzana de la Varga R, Fern\u00e1ndez Natal I. [Cavited pneumonia with <i>Mycobacterium gastri<\/i> positive culture smear]. Rev Clin Esp 208: 237-238, 2008 (in Spanish).","DOI":"10.1016\/S0014-2565(08)71729-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rodriguez JA, Bonnano C, Khatiwada P, Roa AA, Mayer D, Eckardt PA. COVID-19 coinfection with <i>Mycobacterium abscessus<\/i> in a patient with multiple myeloma. Case Rep Infect Dis 2021: 8840536, 2021.","DOI":"10.1155\/2021\/8840536"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ozgur SS, Ansari N, Patel D, Rahman R, Shih R. Rare case of <i>Mycobacterium Avium<\/i> complex peritonitis in a patient with multiple myeloma undergoing peritoneal dialysis. J Community Hosp Intern Med Perspect 14: 54-56, 2024.","DOI":"10.55729\/2000-9666.1300"},{"key":"11","unstructured":"11. Riva E, Garrido D, Villano F, Bove V. Epidemiology and risk factors for the development of infectious complications in newly diagnosed multiple myeloma: a multicenter prospective cohort study in Uruguay. Hematol Transfus Cell Ther. Forthcoming."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sekiguchi E, Kurosawa S, Iketani Y, Yoshimura Y, Nakazato T. Disseminated <i>Mycobacterium kansasii<\/i> infection due to surgical site infection following allogeneic hematopoietic stem cell transplantation: a case report and literature review. Int J Infect Dis 107123, 2024.","DOI":"10.1016\/j.ijid.2024.107123"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. Managed Care Health Plan, 2008-2015. Ann Am Thorac Soc 17: 178-185, 2020.","DOI":"10.1513\/AnnalsATS.201804-236OC"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Schildkraut JA, Gallagher J, Morimoto K, et al. Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation. Respir Med 173: 106164, 2020.","DOI":"10.1016\/j.rmed.2020.106164"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hsi ED, Steinle R, Balasa B, et al. CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma. Clin Cancer Res 14: 2775-2784, 2008.","DOI":"10.1158\/1078-0432.CCR-07-4246"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Richardson PG, Jagannath S, Moreau P, et al. Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study. The Lancet Haematol 2: e516-e527, 2015.","DOI":"10.1016\/S2352-3026(15)00197-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lonial S, Dimopoulos M, Palumbo A, et al. Elotuzumab therapy for relapsed or refractory multiple myeloma. N Engl J Med 373: 621-631, 2015.","DOI":"10.1056\/NEJMoa1505654"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chou YH, Hsu MS, Sheng WH, Chang SC. Disseminated <i>Mycobacterium kansasii<\/i> infection associated with hemophagocytic syndrome. Int J Infect Dis 14: e262-e264, 2010.","DOI":"10.1016\/j.ijid.2009.04.017"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Fordham von Reyn C, Arbeit RD, Tosteson AN, et al. The international epidemiology of disseminated <i>Mycobacterium avium<\/i> complex infection in AIDS. International MAC Study Group. AIDS 10: 1025-1032, 1996.","DOI":"10.1097\/00002030-199610090-00014"},{"key":"20","unstructured":"20. Redoglia V, Boccadoro M, Battaglio S, Dianzani U, Massaia M, Pileri A. Multiple myeloma: altered CD4\/CD8 ratio in bone marrow. Haematologica 75: 129-131, 1990."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Horsburgh CR Jr. The pathophysiology of disseminated <i>Mycobacterium avium<\/i> complex disease in AIDS. J Infect Dis 179 Suppl 3: S461-S465, 1999.","DOI":"10.1086\/314804"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lai CC, Lee LN, Ding LW, Yu CJ, Hsueh PR, Yang PC. Emergence of disseminated infections due to nontuberculous mycobacteria in non-HIV-infected patients, including immunocompetent and immunocompromised patients in a university hospital in Taiwan. J Infect 53: 77-84, 2006.","DOI":"10.1016\/j.jinf.2005.10.009"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin Infect Dis 71: 905-913, 2020.","DOI":"10.1093\/cid\/ciaa1125"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/8\/64_4234-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T03:30:38Z","timestamp":1745033438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/8\/64_4234-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4234-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"article-number":"4234-24"}}